Intestinal Colonization Due to Carbapenem-Resistant Enterobacteriaceae Among Hematological Malignancy Patients in India: Prevalence and Molecular Charecterisation

[1]  A. Manilal,et al.  Gastrointestinal Tract Colonization Rate of Extended-Spectrum Beta-Lactamase- and Carbapenemase-Producing Enterobacteriaceae and Associated Factors Among Hospitalized Patients in Arba Minch General Hospital, Arba Minch, Ethiopia , 2020, Infection and drug resistance.

[2]  J. Benavides,et al.  Fecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae in hospital and community settings in Chad , 2019, Antimicrobial Resistance & Infection Control.

[3]  C. Abad,et al.  495. Risk Factors of Carbapenem-Resistant Enterobacteriaceae (CRE) Infections Among Intensive Care Unit (ICU) Patients in a Tertiary Hospital in the Philippines , 2019, Open Forum Infectious Diseases.

[4]  N. Taneja,et al.  Antimicrobial resistance in the environment: The Indian scenario , 2019, The Indian journal of medical research.

[5]  V. Gopalakrishnan,et al.  Implicating or exonerating the gut microbiome in blood-borne infection , 2018, Nature Medicine.

[6]  J. Robert,et al.  Risk factors for carbapenem-resistant Enterobacteriaceae infections: a French case-control-control study , 2018, European Journal of Clinical Microbiology & Infectious Diseases.

[7]  A. Kapil,et al.  Comparative evaluation of in‐house Carba NP test with other phenotypic tests for rapid detection of carbapenem‐resistant Enterobacteriaceae , 2018, Journal of clinical laboratory analysis.

[8]  A. Kapil,et al.  Bacterial profile and antibiogram of blood stream infections in febrile neutropenic patients with haematological malignancies. , 2018, Journal of infection in developing countries.

[9]  T. Walsh,et al.  Multidrug‐resistant Enterobacteriaceae, Pseudomonas aeruginosa, and vancomycin‐resistant Enterococcus: Three major threats to hematopoietic stem cell transplant recipients , 2017, Transplant infectious disease : an official journal of the Transplantation Society.

[10]  J. Lucet,et al.  Infection prevention and control measures and tools for the prevention of entry of carbapenem-resistant Enterobacteriaceae into healthcare settings: guidance from the European Centre for Disease Prevention and Control , 2017, Antimicrobial Resistance & Infection Control.

[11]  A. Montal,et al.  Carbapenem-resistant Enterobacteriaceae in patients admitted to the emergency department: prevalence, risk factors, and acquisition rate. , 2017, The Journal of hospital infection.

[12]  Hongwei Zhou,et al.  Nationwide Surveillance of Clinical Carbapenem-resistant Enterobacteriaceae (CRE) Strains in China , 2017, EBioMedicine.

[13]  S. Seo,et al.  Multicenter Clinical and Molecular Epidemiological Analysis of Bacteremia Due to Carbapenem-Resistant Enterobacteriaceae (CRE) in the CRE Epicenter of the United States , 2017, Antimicrobial Agents and Chemotherapy.

[14]  B. Gunchin,et al.  Faecal Carriage of Gram-Negative Multidrug-Resistant Bacteria among Patients Hospitalized in Two Centres in Ulaanbaatar, Mongolia , 2016, PloS one.

[15]  L. Pagano,et al.  Bloodstream infections caused by Klebsiella pneumoniae in onco‐hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey , 2016, American journal of hematology.

[16]  S. Esposito,et al.  Carbapenem-resistant Enterobacteriaceae Infections in Children: An Italian Retrospective Multicenter Study , 2016, The Pediatric infectious disease journal.

[17]  G. Kaushik,et al.  Risk factors for fecal carriage of carbapenemase producing Enterobacteriaceae among intensive care unit patients from a tertiary care center in India , 2016, BMC Microbiology.

[18]  D. Knights,et al.  Pretreatment gut microbiome predicts chemotherapy-related bloodstream infection , 2016, Genome Medicine.

[19]  D. Yong,et al.  Mechanisms of ertapenem resistance in Enterobacteriaceae isolates in a tertiary university hospital , 2016, Journal of Investigative Medicine.

[20]  F. Locatelli,et al.  Management of carbapenem resistant Klebsiella pneumoniae infections in stem cell transplant recipients: an Italian multidisciplinary consensus statement , 2015, Haematologica.

[21]  P. Mathur,et al.  Detection of Carbapenemase Production in Gram-negative Bacteria , 2014, Journal of laboratory physicians.

[22]  J. Stachowiak,et al.  The role of the healthcare environment in the spread of multidrug-resistant organisms: update on current best practices for containment , 2014, Therapeutic advances in infectious disease.

[23]  T. Walsh,et al.  The global challenge of carbapenem-resistant Enterobacteriaceae in transplant recipients and patients with hematologic malignancies. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[24]  A. Shorr,et al.  Prevalence of multidrug-resistant Pseudomonas aeruginosa and carbapenem-resistant Enterobacteriaceae among specimens from hospitalized patients with pneumonia and bloodstream infections in the United States from 2000 to 2009. , 2013, Journal of hospital medicine.

[25]  M. Lustberg.  Management of neutropenia in cancer patients. , 2012, Clinical advances in hematology & oncology : H&O.

[26]  S. Dasgupta,et al.  Colonization of the gut with Gram-negative bacilli, its association with neonatal sepsis and its clinical relevance in a developing country. , 2011, Journal of medical microbiology.

[27]  Thierry Naas,et al.  Global Spread of Carbapenemase-producing Enterobacteriaceae , 2011, Emerging infectious diseases.

[28]  N. Woodford,et al.  Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study , 2010, The Lancet. Infectious diseases.

[29]  Timothy R. Walsh,et al.  Characterization of a New Metallo-β-Lactamase Gene, blaNDM-1, and a Novel Erythromycin Esterase Gene Carried on a Unique Genetic Structure in Klebsiella pneumoniae Sequence Type 14 from India , 2009, Antimicrobial Agents and Chemotherapy.

[30]  K. Bush,et al.  Carbapenemases: the Versatile β-Lactamases , 2007, Clinical Microbiology Reviews.

[31]  M. Pilkington,et al.  The Indian Scenario , 2017 .